image

The best stocks to buy since 1993

Latest issue now available

MPAC

April 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • MPAC
  • Price:
  • 456p
MPAC’s shares have made further headway since my last update, with the company introducing its new “Going for Growth” five-year roadmap, aiming to broadly double revenue and improve margins (adj. EBIT margin approximately 10%) in five years.  This follows strong FY23 results, which also reported a stuffed closing order book of £72m.   Having stalled in the early part of the year, revenues improved as the year progressed, going from +4% in H1 to +30% in H2, resulting in a full-year outturn of +17% to £114.2m (a major milestone, exceeding £100m), while pretax profit increased by 103% to £7.1m, with eps up 94% to 25.9p. The Food & Beverage sector accounted for 40% of revenue, with Healthcare at 36% and clean energy contrib ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe